.Five months after Rakovina Therapies rotated towards artificial intelligence, the cancer-focused bi...
.Ascendis Pharma has become a possible danger to BioMarin's Voxzogo, stating period 3 development co...
.Though Alkeus Pharmaceuticals' dental eye disease asset neglected to significantly lessen geographi...
.Along with a trio of biotechs reaching the Nasdaq on Friday, it was quick and easy to overlook a sm...
.Immune checkpoint preventions are the superheroes of cancer treatment. Medicines like Bristol Myers...
.Welcome to today's Chutes & Ladders, our roundup of significant leadership hirings, firings and ...
.Regeneron is back with long-lasting follow-up for its LAG-3 inhibitor and also PD-1 prevention comb...
.AstraZeneca has discussed an early examine the functionality of its own in-house antibody-drug conj...
.After revealing a period 3 launch based upon good midstage end results, iTeos and also GSK are actu...
.The FDA ought to be actually more open as well as collaborative to unleash a surge in commendations...